
Daltontx
The future of drug discovery runs on DaltonTx
- Business Model
- B2B
- Website
- daltontx.com
- Total Funding
- $5.5M
- Last Round
- $5.5M SeedSep 2025
- Rounds
- 1
About
DaltonTx develops adaptive, AI-enabled platforms intended to provide the intelligence backbone for modern drug discovery. Its platform combines drug-discovery expertise, machine learning, human knowledge, and experimental data in a continuous learning workflow. The company positions its products for pharmaceutical, biotech, and contract-research organizations that need more integrated R&D infrastructure.
Summary
Daltontx is an Artificial Intelligence company. It has raised $5.5M in total across 1 round, most recently a $5.5M Seed round in Sep 2025. Investors include Redalpine, IQ Capital Partners and Seedcamp.
Funding History
Sep 2025
Investors
Similar Companies

AI-first drug discovery company using AlphaFold-derived models to design therapeutics and acceler...

OpenAI is an AI research and deployment company dedicated to ensuring that general-purpose artifi...
Anthropic develops reliable, interpretable, and steerable AI systems, translating frontier safety...
xAI builds AI systems, including Grok, with frontier reasoning, voice, and generative media capab...

Waymo is an autonomous driving technology company with a mission to make it safe and easy for peo...

Databricks provides a unified data and AI platform that helps enterprises build and run applicati...
Your company? Embed this profile
Add the live badge to your site — it stays current as your funding data updates.
<a href="https://indexed.vc/companies/daltontx"><img src="https://indexed.vc/api/badge/company/daltontx" alt="Daltontx on Indexed.vc" width="260" height="76" /></a>
